External beam radiotherapy in prostate cancer patients: short- and long-term health-related quality of life issues

References

• Fransson P, Widmark A. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Cancer78(5), 1066–1078 (1996).
   PubMed Web of Science ®Google Scholar
• •Highlights the long-term effects on sexual function assessed with a validated questionnaire.
   Google Scholar
• Lilleby W, Fossa SD, Waehre HR, Olsen DR. Long-term mobidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. mt. j Radiation. Oncol Biol. Phys. 43(4), 735–743 (1999).
   Google Scholar
• Potosky AL, Legler J, Albertsen PC etal Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the prostate cancer outcomes study. J. Natl Cancer Inst. 92(19), 1582–1592 (2000).
   PubMed Web of Science ®Google Scholar
• Altwein J, Ekman P, Barry M et al How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg symposium. Urology 49 (4A), 66–76 (1997).
   Google Scholar
• Fransson P, Widmark A. Late side effects unchanged 4–8 years after radiotherapy for prostate carcinoma. Cancer85(3), 678–688 (1999). Comparison of the long-term effects on bowel and bladder function in the same sample between a 4-and 8-year follow-up.
   Google Scholar
• Holmberg L, Bill-Axelson A, Helgesen F et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl. J. Med. 347(11), 781–789 (2002).
   Google Scholar
• Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schröder PH. Health-related quality of life effects of radical and primary radiotherapy for screen-detected or clinacally diagnosed localized prostate cancer. j Clin. Oncol 19(6), 1619–1628 (2001).
   Google Scholar
• Nguyen LN, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology51,991–997 (1998).
   PubMed Web of Science ®Google Scholar
• Talcott JA, Pieker P, Clark JA et al Patient- reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. j Clin. Oncol 16(1), 275–283 (1998).
   Google Scholar
• Fossa SD, Moynihan C, Serbouti S. Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study. Support Cate Cancer4, 118–128 (1996).
   Google Scholar
• Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br.Cancer57, 109–112 (1988).
   Google Scholar
• Sandler HM, McLaughlin PW, Ten Haken RK, Addison H, Forman J, Lichter A. Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. Int. J. Radiation Oncology Biol. Phys. 33(4), 797–801 (1995).
   Google Scholar
• Borghede G, Hedelin H. Radiotherapy of localized prostate cancer. Analysis of late treatment complications. A prospective study. Radiother. Oncol 43,139–146 (1997).
   PubMed Web of Science ®Google Scholar
• Beard CJ, Lamb C, Buswell L eta]. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. int. J. Radiation Oncology Biol. Phys. 41(2), 257–262 (1998).
   Google Scholar
• Akakura K, Isaka S, Akimoto S eta]. Long- term results of a randomized trial for the treatment of stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. Urology54(2), 313–318 (1999).
   Google Scholar
• Dearnaley DP, Khoo VS, Norman AR etal Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353,267–272 (1999).
   PubMed Web of Science ®Google Scholar
• •Randomized clinical trial comparing conventional and conformal techniques.
   Google Scholar
• Zelefsky MJ, %liner KE, Ling CC etal Comparison of the 5-year outcome and mobidity of 3D conformal radiotherapy versus transperineal permanent Iodine-125 implantation for early-stage prostatic cancer.J Clin. awl 17(2), 517–522 (1999).
   Google Scholar
• Sommers SD, Ramsey SD. A review of quality of life evaluations in prostate cancer. PharmacoEconomics 16 (2), 127–140 (1999).
   PubMedGoogle Scholar
• Hamilton AS, Stanford JL, Gilliland FD et al Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the prostate cancer outcomes study. J Gun. Oncol 19(9), 2517–2526 (2001).
   Google Scholar
• Litwin MS. Health related quality of life in older men without prostate cancer. J Ural161,1180–84 (1999).
   PubMed Web of Science ®Google Scholar
• Litwin MS, McGuigan IKA. Accuracy of recall in health-related quality of life assessment among men treated for prostate cancer. 1 Gun. Oncol 17(9), 2882–2888 (1999).
   Google Scholar
• Turner SL, Adams K, Bull CA, Berry MR Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology54(1), 124–129 (1999).
   PubMed Web of Science ®Google Scholar
• Beard CJ, Propert KJ, Rieker PP eta]. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multi-institutional outcomes study. J Gun. Oncol 15(1), 223–229 (1997).
   Google Scholar
• Mantz CA, Song P, Farhangi E etal Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. Int. J Radiation Oncology Biol. Phys. 37(3), 551–557 (1997).
   Google Scholar
• Beckendorf V, Hay M, Rozan R, Lagrange JL, N'Guyen T, Giraud B. Changes in sexual function after radiotherapy treatment of prostate cancer. BE j UMI. 77, 118–123 (1996).
   Google Scholar
• Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder and sexual function: the patient's perspective. Urology 47 (3), 387–394 (1996).
   PubMedGoogle Scholar
• Widmark A, Fransson P, Tavelin B. Self- assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 74, 2520–2532 (1994).
   Google Scholar
• ••Highlights the long-term effects on boweland bladder function assessed with a validated questionnaire.
   Google Scholar
• Litwin MS, Hays RD, Fink A etal Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273(2), 129–135 (1995).
   PubMed Web of Science ®Google Scholar
• Johnstone PAS, Gray C, Powell C. Quality of life in T1-3 NO prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. int. J Radiation Oncology Biol. Phyc. 46(4), 833–838 (2000).
   Google Scholar
• Niemierko A, Goitein M. Modeling of normal tissue response to radiation: the critical volume model. int. J Radiation Oncology Biol. Riyc. 25,135–145 (1993).
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Leibel SA, Baudin P. Dose escalation with 3D conformal radiation therapy affects outcome in prostate cancer. Int. J Radial Oncol Biol. Phyc. 41,491-500 (1998).
   Google Scholar
• Fuks Z, Horwich A. Clinical and technical aspects of conformal therapy. Radiother. Oncol 29,219–220 (1993).
   Google Scholar
• Fransson P, Damber J-E, Tomic R, Modig H, Nyberg G, Widmark A. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 92(12), 3111–3119 (2001).
   PubMedGoogle Scholar
• Hanlon AL, Bruner DW, Peter R, Hanks GE. Quality of life study in prostate cancer patients treated with 3D conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. int. J Radiation Oncology Biol. iiyc. 49(1), 51–59 (2001).
   Google Scholar
• Roach M, Chinn DM, Holland J, Clarke M. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int. J Radiation Oncology Biol. Phys. 35(5), 869–874 (1996).
   Google Scholar